{"id":62785,"date":"2026-03-13T13:06:55","date_gmt":"2026-03-13T12:06:55","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/alto-neuroscience-announces-participation-at-the-stifel-2026-virtual-cns-forum\/"},"modified":"2026-03-13T13:06:55","modified_gmt":"2026-03-13T12:06:55","slug":"alto-neuroscience-announces-participation-at-the-stifel-2026-virtual-cns-forum","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/alto-neuroscience-announces-participation-at-the-stifel-2026-virtual-cns-forum\/","title":{"rendered":"Alto Neuroscience Announces Participation at the Stifel 2026 Virtual CNS Forum"},"content":{"rendered":"
\n

MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–$anro<\/a> #cns<\/a>–Alto Neuroscience, Inc. (\u201cAlto\u201d) (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced that members of the Company\u2019s management team will participate in a virtual fireside chat at the Stifel 2026 Virtual CNS Forum on March 17, 2026 at 12:00pm ET.<\/p>\n

<\/a>
<\/a><\/p>\n

\nThe presentation will be accessible via a live webcast on the Events and Presentations<\/a> page in the Investors section of Alto\u2019s website and a replay will be available following the presentation.<\/p>\n

\nAbout Alto Neuroscience<\/b><\/p>\n

\nAlto Neuroscience is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging neurobiology to develop personalized and highly effective treatment options. Alto\u2019s Precision Psychiatry Platform\u2122 measures brain biomarkers by analyzing EEG activity, neurocognitive assessments, wearable data, and other factors to better identify which patients are more likely to respond to Alto product candidates. Alto\u2019s clinical-stage pipeline includes novel drug candidates in depression, schizophrenia, and other mental health conditions. For more information, visit www.altoneuroscience.com<\/a> or follow Alto on X.<\/p>\n

\nAvailability of Information on Alto\u2019s Website<\/b><\/p>\n

\nAlto routinely uses its investor relations website to post presentations to investors and other important information, including information that may be material. Accordingly, Alto encourages investors and others interested in Alto to review the information it makes public on its investor relations website.<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor & Media Contact:<\/b>
Nick Smith
\n
investors@altoneuroscience.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–$anro #cns–Alto Neuroscience, Inc. (\u201cAlto\u201d) (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced that members of the Company\u2019s management team will participate in a virtual fireside chat at the Stifel 2026 Virtual CNS Forum on March 17, 2026 at 12:00pm ET. … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62785","6":"format-standard","7":"category-industry"},"yoast_head":"\nAlto Neuroscience Announces Participation at the Stifel 2026 Virtual CNS Forum - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/alto-neuroscience-announces-participation-at-the-stifel-2026-virtual-cns-forum\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alto Neuroscience Announces Participation at the Stifel 2026 Virtual CNS Forum - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–$anro #cns–Alto Neuroscience, Inc. (\u201cAlto\u201d) (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced that members of the Company\u2019s management team will participate in a virtual fireside chat at the Stifel 2026 Virtual CNS Forum on March 17, 2026 at 12:00pm ET. ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/alto-neuroscience-announces-participation-at-the-stifel-2026-virtual-cns-forum\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-13T12:06:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260313166897\/en\/1266385\/22\/Alto_Neuroscience.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alto-neuroscience-announces-participation-at-the-stifel-2026-virtual-cns-forum\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alto-neuroscience-announces-participation-at-the-stifel-2026-virtual-cns-forum\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Alto Neuroscience Announces Participation at the Stifel 2026 Virtual CNS Forum\",\"datePublished\":\"2026-03-13T12:06:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alto-neuroscience-announces-participation-at-the-stifel-2026-virtual-cns-forum\\\/\"},\"wordCount\":247,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alto-neuroscience-announces-participation-at-the-stifel-2026-virtual-cns-forum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260313166897\\\/en\\\/1266385\\\/22\\\/Alto_Neuroscience.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alto-neuroscience-announces-participation-at-the-stifel-2026-virtual-cns-forum\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alto-neuroscience-announces-participation-at-the-stifel-2026-virtual-cns-forum\\\/\",\"name\":\"Alto Neuroscience Announces Participation at the Stifel 2026 Virtual CNS Forum - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alto-neuroscience-announces-participation-at-the-stifel-2026-virtual-cns-forum\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alto-neuroscience-announces-participation-at-the-stifel-2026-virtual-cns-forum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260313166897\\\/en\\\/1266385\\\/22\\\/Alto_Neuroscience.jpg\",\"datePublished\":\"2026-03-13T12:06:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alto-neuroscience-announces-participation-at-the-stifel-2026-virtual-cns-forum\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alto-neuroscience-announces-participation-at-the-stifel-2026-virtual-cns-forum\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alto-neuroscience-announces-participation-at-the-stifel-2026-virtual-cns-forum\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260313166897\\\/en\\\/1266385\\\/22\\\/Alto_Neuroscience.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260313166897\\\/en\\\/1266385\\\/22\\\/Alto_Neuroscience.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alto-neuroscience-announces-participation-at-the-stifel-2026-virtual-cns-forum\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alto Neuroscience Announces Participation at the Stifel 2026 Virtual CNS Forum\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Alto Neuroscience Announces Participation at the Stifel 2026 Virtual CNS Forum - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/alto-neuroscience-announces-participation-at-the-stifel-2026-virtual-cns-forum\/","og_locale":"en_US","og_type":"article","og_title":"Alto Neuroscience Announces Participation at the Stifel 2026 Virtual CNS Forum - Pharma Trend","og_description":"MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–$anro #cns–Alto Neuroscience, Inc. (\u201cAlto\u201d) (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced that members of the Company\u2019s management team will participate in a virtual fireside chat at the Stifel 2026 Virtual CNS Forum on March 17, 2026 at 12:00pm ET. ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/alto-neuroscience-announces-participation-at-the-stifel-2026-virtual-cns-forum\/","og_site_name":"Pharma Trend","article_published_time":"2026-03-13T12:06:55+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260313166897\/en\/1266385\/22\/Alto_Neuroscience.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/alto-neuroscience-announces-participation-at-the-stifel-2026-virtual-cns-forum\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/alto-neuroscience-announces-participation-at-the-stifel-2026-virtual-cns-forum\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Alto Neuroscience Announces Participation at the Stifel 2026 Virtual CNS Forum","datePublished":"2026-03-13T12:06:55+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/alto-neuroscience-announces-participation-at-the-stifel-2026-virtual-cns-forum\/"},"wordCount":247,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/alto-neuroscience-announces-participation-at-the-stifel-2026-virtual-cns-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260313166897\/en\/1266385\/22\/Alto_Neuroscience.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/alto-neuroscience-announces-participation-at-the-stifel-2026-virtual-cns-forum\/","url":"https:\/\/pharma-trend.com\/en\/alto-neuroscience-announces-participation-at-the-stifel-2026-virtual-cns-forum\/","name":"Alto Neuroscience Announces Participation at the Stifel 2026 Virtual CNS Forum - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/alto-neuroscience-announces-participation-at-the-stifel-2026-virtual-cns-forum\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/alto-neuroscience-announces-participation-at-the-stifel-2026-virtual-cns-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260313166897\/en\/1266385\/22\/Alto_Neuroscience.jpg","datePublished":"2026-03-13T12:06:55+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/alto-neuroscience-announces-participation-at-the-stifel-2026-virtual-cns-forum\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/alto-neuroscience-announces-participation-at-the-stifel-2026-virtual-cns-forum\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/alto-neuroscience-announces-participation-at-the-stifel-2026-virtual-cns-forum\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260313166897\/en\/1266385\/22\/Alto_Neuroscience.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260313166897\/en\/1266385\/22\/Alto_Neuroscience.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/alto-neuroscience-announces-participation-at-the-stifel-2026-virtual-cns-forum\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Alto Neuroscience Announces Participation at the Stifel 2026 Virtual CNS Forum"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62785","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62785"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62785\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62785"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62785"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62785"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}